nibentan

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2013
024619972013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
An HPLC method with electrospray ionization and ion-trap mass spectral detection (LC-ESI/MSD Ion Trap SL) for determining… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2008
2008
AIM To study efficacy and safety of using a domestic anti-arrhythmic drug nibentan for arresting acute atrial fibrillation… (More)
Is this relevant?
2006
2006
Rats. Each experiment was performed with a group of 15 2 0 intact white mongrel intact rats weighing about 100 g. One day before… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2006
2006
Proxodolol is an original "hybrid" 13-adrenoblocking drug allowed for practical application as an antihypertensive, antianginal… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2005
2005
AIM To assess efficacy of a potassium channel blocker nibentan for pharmacological cardioversion of persistent atrial… (More)
Is this relevant?
2004
2004
Nibentan is the first original domestic antiarrhythmic (group III) drug, created in cooperation with the Center for Drug… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2000
2000
Nibentan, a new class III antiarrhythmic drug, is highly effective in patients with atrial flutter and fibrillation. However, its… (More)
Is this relevant?
2000
2000
A series of 1,5-diaminopentane derivatives, structurally related to nibentan, was synthesized and tested for antifibrillatory… (More)
Is this relevant?
1998
1998
The paper presents experimental and clinical findings of the new antiarrhythmic drug nibentan. The agent was found to be a class… (More)
Is this relevant?
1997
1997
We studied the effects of nibentan on transmembrane action potentials of canine Purkinje fibers (PF), ventricular epicardial and… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?